Canakinumab therapy in patients with Familial Mediterranean Fever

Documenti analoghi

• PW01-012 – Canakinumab in patients with FMF
  di: Ugurlu, S, et al.
  Pubblicazione: (2013)
• Is Familial Mediterranean Fever a clinical diagnosis? Results of a field survey
  di: Ozdogan, H, et al.
  Pubblicazione: (2015)
• Anakinra treatment in patients with Familial Mediterranean Fever: a single-center experience
  di: Ugurlu, S, et al.
  Pubblicazione: (2015)
• Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever
  di: Gül, Ahmet, et al.
  Pubblicazione: (2015)
• The IL-1 inhibitor Canakinumab for Familial Mediterranean Fever: the Greek experience in 12 patients
  di: Laskari, K, et al.
  Pubblicazione: (2015)